Haojie Shan | Medicine | Best Researcher Award

Posted on by ScienceFather

Haojie Shan | Medicine | Best Researcher Award

Resident Surgeon at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School, China.

Dr. Haojie Shan is a dedicated resident surgeon specializing in orthopaedics at Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. With a strong clinical and research foundation, Dr. Shan is passionate about advancing orthopaedic treatments, focusing on challenging areas such as osteonecrosis of the femoral head, bone immunity, and regeneration. His contributions to orthopaedics have been recognized through multiple prestigious awards, highlighting his commitment to innovation. Dr. Shan’s blend of clinical expertise and research excellence positions him as an emerging leader in orthopaedics, driven to enhance patient care and develop novel medical solutions.

Publication Profile

Scopus

Education

Dr. Shan completed his Ph.D. in Surgery (Orthopaedics) in 2023 at Shanghai Jiao Tong University, where he also earned his MD in 2020. He first obtained his Bachelor of Science in Clinical Medicine from Henan University in 2017. Each stage of his education has been marked by rigorous training, both in clinical practice and research, equipping him with a comprehensive understanding of orthopaedic medicine. This academic progression underscores Dr. Shan’s commitment to mastering complex medical challenges, particularly in his chosen field of orthopaedics, and provides a strong foundation for his clinical and research career.

Professional Experience

Currently, Dr. Shan is a resident surgeon in orthopaedics at Shanghai Sixth People’s Hospital. In this role, he has gained practical experience managing complex orthopaedic cases, with a focus on surgical techniques and postoperative care. His position at this leading hospital allows him to integrate his research insights with clinical practice, enhancing patient care with innovative approaches. His exposure to diverse cases has refined his skills in addressing issues like bone regeneration and infection control, which align with his research interests. Dr. Shan’s experience exemplifies his dedication to combining clinical expertise with research-driven improvements in orthopaedic care.

Research Focus

Dr. Shan’s research focuses on osteonecrosis of the femoral head, bone immunity, bone regeneration, and biomedical materials. His work seeks to address significant challenges in orthopaedic surgery, such as restoring bone function and preventing infection in complex cases. Dr. Shan is particularly interested in innovative treatments that promote healing and enhance patient outcomes. His research on bone and soft tissue infection and immunity explores the interactions between implants and the body’s immune response. Through his investigations, Dr. Shan aims to bridge scientific discovery and clinical application, advancing orthopaedic treatment methods and expanding therapeutic options in the field.

Awards and Honors

Dr. Shan has received multiple prestigious awards, reflecting his contributions to orthopaedics and medical innovation. In 2024, he won the Gold Award in the Shanghai Division and the National Silver Award at the International Innovation Competition for College Students in China. Additionally, he earned First Prize in the Rehabilitation Medicine and Engineering Innovation Competition (2023) and accolades for his papers at major conferences. His achievements also include third-place awards in the China Medical Device Innovation Competition and the Shanghai Orthopedics Annual Meeting. These recognitions underscore Dr. Shan’s dedication to advancing orthopaedic science and patient care.

Conclusion

Overall, Dr. Haojie Shan demonstrates strong qualifications for the “Best Researcher Award” based on his academic background, innovative research, and significant recognition within orthopaedics. Enhancing international visibility through collaborations and publications could further elevate his standing. Given his notable achievements and ongoing impact, he is a well-qualified candidate for the award.

Publication Top Notes 

Title: A chitosan/gelatin/aldehyde hyaluronic acid hydrogel coating releasing calcium ions and vancomycin in pH response to prevent the formation of bacterial biofilm
Authors: Li, Y., Sung Min, H., Chen, C., … Lu, L., Yu, X.
Year: 2025
Journal: Carbohydrate Polymers, 347, 122723
Citations: 0

Title: Copper-infused zinc porphyrin supramolecular polymersomes for triple synergistic combat against wound bacterial biofilm infections
Authors: Yang, L., Du, Y., Yin, F., … Zhou, Y., Yu, X.
Year: 2024
Journal: Aggregate
Citations: 0

Title: An Intelligent Hydrogel Platform with Triple-Triggered On-Demand Release for Accelerating Diabetic Wound Healing
Authors: Zhang, X., Li, Y., Zhao, Z., … Ren, R., Du, C.
Year: 2024
Journal: Small Methods
Citations: 0

Title: Scd-1 deficiency promotes the differentiation of CD8+ T effector
Authors: Lin, Y., Li, X., Shan, H., … Liu, F., Yu, X.
Year: 2024
Journal: Frontiers in Cellular and Infection Microbiology, 14, 1325390
Citations: 1

Title: Effects of astragaloside IV on glucocorticoid-induced avascular necrosis of the femoral head via regulating Akt-related pathways
Authors: Shan, H., Lin, Y., Yin, F., … Zhou, Z., Yu, X.
Year: 2023
Journal: Cell Proliferation, 56(11), e13485
Citations: 4

Title: Dimethyl Oxalylglycine Activates Tendon-Derived Stem Cells to Promote Regeneration of Achilles Tendon Rupture in Rats via HIF-1α
Authors: Wang, Y., Li, M., Lin, Y., … Shan, H., Wu, T.
Year: 2023
Journal: Advanced Therapeutics, 6(3), 2200164
Citations: 2

Title: The Ubiquitination of RIPK2 is Mediated by Peli3 and Negatively Regulates the Onset of Infectious Osteomyelitis
Authors: Le, L., Shan, H., Lin, Y., … Shi, Z., Xu, Y.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(4), pp. 240–245
Citations: 0

Title: Ubiquitin-Specific Peptidase 8 Is Critical for the Onset of Infectious Osteomyelitis by Targeting RIPK2 Ubiquitination
Authors: Chen, Y., Wan, Y., Shan, H., … Jiang, C., Shi, Z.
Year: 2023
Journal: Japanese Journal of Infectious Diseases, 76(3), pp. 197–203
Citations: 0

Title: Staphylococcus aureus Infection Initiates Hypoxia-Mediated Transforming Growth Factor-b1 Upregulation to Trigger Osteomyelitis
Authors: Zhang, W., Lin, Y., Zong, Y., … Zhou, Z., Yu, X.
Year: 2022
Journal: mSystems, 7(4)
Citations: 9

 

Fei Yu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Fei Yu | Medicine and Dentistry | Best Researcher Award

Prof Fei Yu, Shanghai tenth people’s hospital, China

Prof. Fei Yu, a distinguished expert in Nuclear Medicine, holds a rich educational background with degrees from Soochow University and Fudan University. With a graduation date of June 2012 from Soochow University School of Medicine, he has dedicated himself to advancing the field of Nuclear Medicine through significant contributions and research.

Publication profile

Scopus

Education

Prof. Fei Yu graduated in June 2012 from Soochow University, where he completed his medical education. He previously attended Fudan University from September 1996 to July 2001, earning his degree from the School of Public Health and Community Medicine. Furthering his studies, Prof. Yu obtained his degree from Tongji University’s School of Medicine between March 2005 and March 2008. With a strong foundation in public health and medicine, he has made significant contributions to his field. 🌍📚🏥

Honors and Awards

Prof. Fei Yu is a distinguished researcher recognized for his significant contributions to nuclear medicine. He was awarded the Star of Hope Award by the Chinese Society of Nuclear Medicine in September 2018. His project on targeted therapy for non-small cell lung cancer, supported by the Shanghai Talent Development Fund in September 2017, highlights his innovative approach in the field. He also received the Shanghai Science and Technology Award in November 2010 for developing a 99mTc labeled somatostatin receptor imaging kit for lung cancer diagnosis. Additionally, he was honored with the Huaxia Medical Science and Technology Award and the Hospital Technology Innovation Award for his research on medical ethics and intelligent clinical pathways. 🌟🔬🏆

Research Achievements

Dr. Yang and colleagues have made significant strides in cancer therapy and cardiology. Their 2024 study in Theranostics explores how damaged mitochondrial transfer impacts the bystander effect induced by alpha-particle radiation (🎗️). Another study published in Small reveals that alpha-emitter Radium-223 triggers STING-dependent pyroptosis, enhancing antitumor immunity (💉). Additionally, they developed alpha radionuclide-chelated radioimmunotherapy promoters to advance local radiotherapy strategies, published in Biomaterials Research (📚). In cardiology, their nomogram for predicting major adverse cardiac events in patients with ischemia, featured in Frontiers in Cardiovascular Medicine, is a pivotal contribution (❤️).

Research focus

Prof. Fei Yu is a prominent researcher specializing in nuclear medicine and molecular imaging. His work encompasses the development and evaluation of advanced therapeutic approaches, particularly in the context of neuroendocrine tumors and thyroid cancer. Prof. Yu’s research focuses on innovative treatments like peptide receptor radionuclide therapy and the mechanisms of antitumor immunity, including the role of STING-dependent pyroptosis induced by alpha-emitter Radium-223. His contributions significantly enhance understanding of cancer therapies and their implications for patient prognosis. 🔬💉📈

Memberships and Leadership

Prof. Yu is an active member of several professional societies, holding key positions such as Vice Chairman of the Continuing Education Committee of Nuclear Medicine under the Chinese Nuclear Society. His involvement in these organizations reflects his dedication to the growth and education within the field, emphasizing the importance of collaboration and knowledge sharing.

Funding and Research Projects

Prof. Yu leads multiple funded projects, including the National Natural Science Foundation project on interstitial radiotherapy combined with immunotherapy for non-small cell lung cancer. His work is characterized by a strong focus on innovative therapies that integrate radiological techniques with emerging treatment modalities.

Publication top notes

Triglyceride-glucose index is associated with myocardial ischemia and poor prognosis in patients with ischemia and no obstructive coronary artery disease

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes

The Effect of Radioiodine Therapy on the Prognosis of Differentiated Thyroid Cancer with Lung Metastases

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity

Conclusion

Prof. Fei Yu exemplifies excellence in nuclear medicine, with a career marked by substantial research contributions, leadership roles, and a commitment to advancing medical science. His innovative approaches to cancer therapy and active involvement in professional societies make him an outstanding candidate for the Best Researcher Award. Prof. Yu’s dedication to improving patient outcomes through research and education sets a high standard for future professionals in the field.

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Ashwani Singal | Medicine  and Dentistry | Best Researcher Award

Prof Ashwani Singal, University of Louisville School of Medicine, United States

Prof. Ashwani Singal, he appears to be a highly suitable candidate for the Best Researcher Award. Here are several reasons supporting this nomination:

Publication Profile

Google Scholar

Research and Academic Excellence

  • Extensive Education: Prof. Singal holds an MBBS, MD in Medicine, and a DM in Gastroenterology, along with postdoctoral training in Transplant Hepatology and Gastroenterology from prestigious institutions like Mayo Clinic and UTMB Galveston.
  • Publications: He has a substantial publication record, including influential papers on liver diseases, alcoholic liver disease, and hepatitis C, demonstrating his contributions to advancing medical knowledge in his field. His work has been recognized in reputable journals and conferences, with multiple posters of distinction presented at AASLD annual conferences.

Clinical Impact

  • Leadership Roles: As the Medical Director of Liver Transplant at the Trager Transplant Institute and a Transplant Hepatologist at Avera Transplant Institute, he plays a critical role in clinical practice and patient care, impacting many lives.
  • Current Support: His involvement in multiple funded research projects indicates ongoing commitment to advancing research in alcohol use disorders and liver diseases, with significant financial backing from NIH and other organizations.

Contributions to Medical Education

  • Teaching and Mentoring: Prof. Singal has extensive experience in teaching medical students and residents across various institutions, having served as a course director and providing numerous lectures and grand rounds. His mentorship has led to several mentees receiving awards for their research.

Professional Engagement

  • Committee Involvement: He has served on numerous committees and councils within professional societies, showcasing his dedication to improving the field of gastroenterology and hepatology.
  • Editorial Roles: Prof. Singal is active in the editorial boards of reputable journals, contributing to the peer-review process and shaping future research directions in his specialty.

Recognition and Awards

  • Recent Nominations: His nomination for the Clinical Innovation Award by the Healio-American College of Gastroenterology and his status as an International Fellow of the National Academy of Medical Science in India highlight his recognition as a leader in his field.

Publication Top Notes

ACG clinical guideline: alcoholic liver disease

The Bioenergetic Health Index: a new concept in mitochondrial translational research

Evolving frequency and outcomes of liver transplantation based on etiology of liver disease

Antioxidants as therapeutic agents for liver disease

Hepatitis C virus and hepatocellular carcinoma: a narrative review

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus–related cirrhosis

Mesenteric venous thrombosis

 

Conclusion

Prof. Ashwani Singal’s extensive academic credentials, significant clinical contributions, commitment to education, active engagement in professional societies, and recognition in the form of awards and nominations make him an exemplary candidate for the Best Researcher Award. His work not only contributes to advancing medical knowledge but also directly impacts patient care and the training of future healthcare professionals.

Mehmet Nur Kaya | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Mehmet Nur Kaya | Medicine and Dentistry | Young Scientist Award

researcher, Gülhane Training and Research Hospital,  Rheumatology Department , Turkey

The study titled “Impact of Central Sensitization on Clinical and Functional Aspects of Psoriatic Arthritis” by Mehmet Nur Kaya et al. examines the prevalence of central sensitization (CS) in patients with psoriatic arthritis (PsA). Conducted with 103 PsA patients, the research used the Central Sensitization Inventory (CSI) to assess CS’s influence on clinical and functional markers such as disease activity, sleep quality, depression, and anxiety. The study found that 65.1% of the patients had CS, with the Psoriasis Area Severity Index (PASI), General Anxiety Disorder-7 (GAD-7), and Insomnia Severity Index (ISI) emerging as significant predictors of CS. Patients with CS demonstrated higher BMI and disease activity scores. The research highlights the importance of considering CS when assessing pain sensitivity in PsA patients. These findings underscore the potential impact of CS on clinical management, with implications for treatment strategies aimed at improving quality of life in PsA patients.

Profile:

Education

Mehmet Nur Kaya, a distinguished researcher in the field of rheumatology, earned his medical degree from a reputable institution and pursued further specialization in rheumatology. He is currently affiliated with the Rheumatology Department at Gülhane Training and Research Hospital, University of Health Sciences in Turkey. His academic journey reflects a commitment to understanding complex rheumatic diseases, particularly psoriatic arthritis (PsA). Through continuous learning and hands-on experience, Kaya has honed his skills in clinical research, diagnostics, and patient care, contributing to the advancement of medical knowledge in his field. His educational background, coupled with extensive clinical experience, has enabled him to conduct pioneering studies on central sensitization in PsA, shedding light on critical aspects of pain management and disease activity. Kaya’s dedication to education and research underscores his role as a key contributor to both academic and clinical advancements in rheumatology.

 

Professional Experiences

Dr. Mehmet Nur Kaya is a dedicated rheumatologist with extensive experience in the study and management of psoriatic arthritis (PsA) and other rheumatic conditions. As part of the Rheumatology Department at Gülhane Training and Research Hospital, University of Health Sciences, Turkey, he has made significant contributions to understanding the clinical and functional impacts of central sensitization (CS) on PsA patients. Dr. Kaya has collaborated with renowned professionals, leading numerous observational studies focused on pain sensitivity, quality of life, disease activity, and treatment outcomes in rheumatic diseases. His work with patient-centric assessments, such as the Central Sensitization Inventory (CSI), has played a critical role in shaping treatment protocols and improving patient care. Dr. Kaya is committed to advancing the field of rheumatology, combining clinical expertise with a passion for research, and continually striving to enhance the quality of life for individuals affected by chronic inflammatory diseases.

 

Research Skills

Research skills are essential for effectively gathering, analyzing, and interpreting information across various fields. These skills encompass critical thinking, allowing individuals to evaluate sources, discern credible information, and synthesize diverse viewpoints. Proficiency in quantitative and qualitative research methodologies is crucial, enabling researchers to design studies, collect data, and draw valid conclusions. Effective communication is another vital component, as researchers must articulate their findings clearly through written reports and presentations. Additionally, strong organizational skills facilitate the management of research timelines, resources, and documentation. Familiarity with digital tools and databases enhances the ability to access and utilize a wide range of resources efficiently. Lastly, ethical considerations in research, such as maintaining integrity and respecting confidentiality, are paramount to uphold the credibility of one’s work. Developing these research skills not only fosters academic and professional growth but also contributes to informed decision-making in an increasingly complex world.

Award And Recognition

The Research for Young Scientist Award recognizes outstanding contributions made by emerging researchers in the field of medical sciences, specifically focusing on the impact of central sensitization on psoriatic arthritis. This award aims to honor innovative research that enhances our understanding of chronic inflammatory diseases and their effects on patients’ quality of life. Candidates are evaluated based on their scientific rigor, originality, and potential for future contributions to the field. The award serves not only to celebrate individual achievements but also to inspire young scientists to pursue impactful research that addresses pressing health challenges. By fostering a culture of excellence and innovation, the Research for Young Scientist Award promotes the dissemination of knowledge and encourages collaboration among researchers. This recognition plays a crucial role in motivating young professionals to advance their careers and contribute significantly to the medical community.

Conclusion

The research conducted by Kaya et al. on the impact of central sensitization (CS) in patients with psoriatic arthritis (PsA) provides crucial insights into the complex interplay between pain sensitivity and disease severity. Their findings reveal that a significant proportion of PsA patients experience CS, which is associated with higher disease activity, impaired quality of life, and increased severity of psychological symptoms such as anxiety and insomnia. By utilizing the Central Sensitization Inventory (CSI), the study effectively highlights the importance of recognizing CS as a critical factor influencing the clinical and functional outcomes of PsA. The results underscore the need for healthcare professionals to consider CS in pain management strategies, aiming to improve the overall treatment approach for PsA patients. This research not only enhances the understanding of pain mechanisms in PsA but also emphasizes the necessity of comprehensive assessments to tailor interventions that address both physical and psychological aspects of the disease.

Publication Top Notes

  1. Drug-free remission is an achievable target with immunosuppressive treatment in idiopathic granulomatous mastitis
    Authors: Kaya, M.N., Tekgöz, E., Çolak, S., Çınar, M., Yılmaz, S.
    Year: 2023
    Citations: 3
    Journal: Irish Journal of Medical Science, 192(6), pp. 2815–2819
  2. Can pre-treatment inflammatory biomarker levels predict the response of tocilizumab therapy in COVID-19 patients?
    Authors: Kaya, M.N., Tecer, D., Çınar, M., Çolak, S., Yılmaz, S.
    Year: 2023
    Citations: 1
    Journal: Gulhane Medical Journal, 65(4), pp. 145–151
  3. Hospital-acquired anemia in chronic kidney disease
    Authors: Kaya, M.N., Caner, B., Toprak, Ö.
    Year: 2019
    Citations: 0
    Journal: International Journal of Scientific and Technology Research, 8(4), pp. 160–166

khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Posted on by ScienceFather

Dr. khadijeh kalanfarmanfarma | Health Professions Award | Best Researcher Award

Dr. khadijeh kalanfarmanfarma, Kashan University of Medical Sciences, Kashan, Iran

Dr. Khadijeh Kalan Farmanfarma (born April 24, 1978) holds a PhD in Epidemiology and an M.Sc. in Health Education and Promotion. She has been recognized as a top researcher at both the national and university levels, notably at Zahedan University of Medical Sciences. Dr. Farmanfarma has contributed to over 20 high-impact publications, focusing on cancer epidemiology, metabolic syndrome, and public health. She is also a co-author of an eBook on the Renin-Angiotensin System and its role in diseases. Her research has earned her awards and recognition both nationally and internationally. 📚🌍🔬

 

Publication profile

Academic Background 🧠

Dr. Khadijeh Kalan Farmanfarma holds a PhD in Epidemiology and an M.Sc. in Health Education and Health Promotion. Her solid academic foundation is supported by multiple recognitions at the doctoral and master’s levels. Her focus on epidemiological research is crucial, particularly during global health challenges like COVID-19.

Research Contributions 📚

Dr. Farmanfarma has an impressive body of work, with more than 25 published research articles across Q1 to Q3 journals. Some highlights include:

COVID-19 Research: Her studies on the impact of COVID-19, especially on domestic violence and illness anxiety, show her commitment to addressing emerging public health issues.

Metabolic Syndrome & Cancer Epidemiology: Dr. Farmanfarma has published meta-analyses on metabolic syndrome and various cancers, which have gained significant attention in high-impact journals like Diabetes & Metabolic Syndrome: Clinical Research & Reviews (IF: 10.0, Q1).

Chronic Diseases & Breast Cancer Prevention: Her focus on chronic diseases and breast cancer prevention demonstrates her dedication to improving population health.

Recognitions 🏆

Dr. Farmanfarma’s accolades include being named the Top National Researcher and Top Researcher at Zahedan University of Medical Sciences multiple times, which speaks to her consistent excellence in research.

Publication Top Notes 

  • 📚 Prevalence of metabolic syndrome in Middle-East countries: Meta-analysis of cross-sectional studies – Cited by: 248 (2018)
  • 📚 Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies – Cited by: 149 (2019)
  • 🧠 Brain cancer in the world: An epidemiological review – Cited by: 79 (2019)
  • 🎗️ Improving Breast Cancer Preventive Behavior among Female Medical Staff: Educational Intervention – Cited by: 59 (2014)
  • 📊 Epidemiologic study of gastric cancer in Iran: A systematic review – Cited by: 51 (2020)
  • 📈 Prevalence of type 2 diabetes in Middle-East: Systematic review & meta-analysis – Cited by: 47 (2020)
  • 🎗️ Effect of education on preventive behaviors of breast cancer in female teachers – Cited by: 35 (2014)
  • 🩺 Study of breast cancer knowledge, attitude, and preventive behaviors in Yazd, Iran – Cited by: 22 (2017)
  • 📊 Prevalence and trend of metabolic syndrome in South-East Iran – Cited by: 21 (2020)
  • 🧬 Testicular cancer in the world: An epidemiological review – Cited by: 20 (2018)

Conclusion 📝

With her extensive research output, recognitions, and focus on significant public health issues, Dr. Khadijeh Kalan Farmanfarma is a strong candidate for the Research for Best Researcher Award. Her diverse and impactful research contributions in epidemiology, particularly in chronic diseases and cancer, reflect a distinguished career deserving of recognition.

 

 

Linette Thorn | Health Professions | Best Researcher Award

Posted on by ScienceFather

Ms. Linette Thorn | Health Professions | Best Researcher Award

Ms. Linette Thorn, Aarhus University Hospital, Denmark

Based on Linette Thorn’s curriculum vitae, she appears to be a strong candidate for the “Research for Best Researcher Award.” Here’s a detailed evaluation of her qualifications:

Publication profile

Educational Background

Linette Thorn has a solid educational foundation, including a Master’s degree in Nursing Science from Aarhus University and intensive care nurse training. Her education is complemented by various specialized courses, such as NVivo and STATA, which underscore her commitment to advancing her research skills. 📚🎓

Professional Experience

With extensive experience in intensive care settings since 2007, Thorn’s roles span from intensive care nurse to project nurse in significant research projects. Her work with ICU-CogHab and ‘Live music in the ICU’ demonstrates a strong focus on innovative approaches to patient care. Her roles highlight her expertise in both clinical practice and research. 🏥🔬

Research Contributions

Thorn has been involved in notable research projects, including studies on live music’s impact in the ICU and cognitive rehabilitation for ICU patients. Her publications in peer-reviewed journals like the Australian Critical Care and International Journal of Qualitative Studies on Health and Well-being reflect a significant contribution to her field. Her research is funded by prestigious organizations, such as The Novo Nordisk Foundation. 📊🔍

Invited Speaker and Presentations

Her presentations at various international conferences, including the European Conference Culture for Health, showcase her ability to communicate complex research findings effectively. These speaking engagements reinforce her position as a thought leader in her field. 🎤🌍

Funding and Scholarships

Thorn has secured substantial funding for her research, including the Athena Award and project grants from The Novo Nordisk Foundation. This financial support is indicative of her research’s value and impact. 💰🏆

Publications

  • Collet, M.O., Nielsen, A.H., Larsen, L.K., Rahr, M.N., Svenningsen, H. (2024). Delirium and delirium severity screening in the intensive care—correspondence of screenings tools. Australian Critical Care, 37(3), pp. 407–413. 📅🔍
  • Dreyer, P., Thorn, L., Lund, T.H., Bro, M.L. (2024). Live music in the intensive care unit–a beautiful experience. International Journal of Qualitative Studies on Health and Well-being, 19(1), 2322755. 📅🎵
  • Nielsen, A.H., Larsen, L.K., Collet, M.O., Rahr, M.N., Svenningsen, H. (2023). Intensive care unit nurses’ perception of three different methods for delirium screening: A survey (DELIS-3). Australian Critical Care, 36(6), pp. 1035–1042. 📅🔍
  • Collet, M.O., Nielsen, G.M., Bang, B., Lange, T., Egerod, I. (2021). Does rocking motion calm delirious patients in ICU? A multicentre randomised clinical trial protocol (RockingICU). Acta Anaesthesiologica Scandinavica, 65(7), pp. 995–1001. 📅🪑

Conclusion

Linette Thorn’s extensive experience, impactful research, notable presentations, and successful funding applications position her as an exemplary candidate for the “Research for Best Researcher Award.” Her contributions to nursing research and patient care, combined with her strong academic and professional background, make her a deserving recipient of this honor. 🌟🎉

 

Enguo Cao | Health Professions | Best Researcher Award

Posted on by ScienceFather

Enguo Cao | Health Professions | Best Researcher Award

Prof Dr Enguo Cao, Jiangnan University, China

Prof. Cao Enguo 🧑‍🏫 is a distinguished professor and doctoral supervisor at Jiangnan University, China. With a Ph.D. from Japan, he leads the Intelligent Interaction Design Laboratory and serves as deputy director of the Key Laboratory of China Light Industry. His research focuses on intelligent product design and human biomimetic interaction, resulting in over 30 papers and 20+ patents. He has led numerous research projects, including grants from the National Natural Science Foundation of China. Prof. Cao has earned several accolades, including the Yoneyama Rotary Memorial Award and the title of “Top Six Talent Peaks” in Jiangsu Province. 🌟🔬📚

Publication profile

Scopus

Research Interests

Intelligent Interaction System Design focuses on creating advanced systems that enhance user experiences through smart and responsive technology. This field encompasses the development of interactive interfaces that adapt to user needs, leveraging artificial intelligence and machine learning to offer intuitive and personalized interactions. The goal is to build systems that not only respond to user inputs but also predict and adapt to their preferences, providing a seamless and engaging experience. Such designs are pivotal in various applications, from smart home devices to sophisticated customer service bots, aiming to make technology more accessible and user-friendly.

Research focus

Dr. Enguo Cao’s research primarily focuses on wearable health devices, exoskeleton design, and user experience in robotics. His work includes designing and evaluating various types of exoskeletons for rehabilitation and mobility enhancement, such as passive lower limb exoskeletons and multi-resiliency models. He also explores the integration of emotional and social factors into user experience, aiming to improve interaction with automated systems and devices. His contributions include studies on the physiological effects of exoskeletons during physical activities and data-driven frameworks for predicting user expectations. His research is crucial for advancing assistive technologies and enhancing their practical application. 🤖🦵📊

Publication top notes

User Experience & Usability of Wearable Health Device: A Bibliometric Analysis of 2014–2023

Multi-motion Compound Passive Lower Limb Exoskeleton Design and Its Intelligent Interaction Evaluation 

Design and evaluation of a double rope rehabilitation robot for sit-to-stand training

Exploring the Positive User Experience Possibilities Based on Produc

Design of a multi-resiliency exoskeleton and its physiologic cost evaluation in uphill walking and stair climbing locomotion

A Data-Driven Expectation Prediction Framework Based on Social Exchange Theory

Design and performance evaluation of gravitational potential energy locking exoskeleton 

Design of cyber-physical-social systems with forensic-awareness based on deep learning

Design and optimization of a passive exoskeleton mechanical foot

 

 

 

Tang Gao | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Tang Gao | Medicine and Dentistry | Best Researcher Award

Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China

Dr. Tang Gao, renowned for groundbreaking research in Medicine and Dentistry, has been honored with the prestigious Best Researcher Award. His exceptional contributions at Huazhong University of Science and Technology Tongji Medical College Affiliated Union Hospital, China, have significantly advanced healthcare knowledge and patient care. 🏆 Dr. Gao’s dedication to pioneering research not only inspires his peers but also enhances medical practices worldwide, setting a benchmark for excellence in academia and healthcare innovation.

Profile

Google Scholar

Education

Dr. Tang Gao is a dedicated professional with a strong academic background in medicine. He graduated from Hubei University of Chinese Medicine with a Bachelor’s degree in pharmacy in 2013, followed by a Master of Medicine from Central South University in 2016, and a Doctorate in Medicine in 2019. His journey reflects a deep commitment to advancing medical knowledge and expertise. 🎓 Dr. Gao’s academic pursuits have equipped him with a comprehensive understanding of pharmaceutical sciences and clinical practice, positioning him well to contribute significantly to the field of medicine.

Research and work experience

Dr. Tang Gao completed his post-doctoral work at Union Hospital, Tongji Medical College of HUST from October 2019 to June 2022. Since July 2022, he has served as an Assistant Professor at the same institution. His research focuses on [mention specific research interests if known]. With a commitment to advancing medical knowledge and education, Dr. Gao brings a wealth of experience and dedication to his role. 🎓 His contributions to academia and healthcare underscore his passion for bridging theory with practical application in medicine.

Projects

Dr. Tang Gao has secured several research grants to advance medical diagnostics and treatment modalities, focusing notably on heart transplant rejection and infectious disease detection. 🌟 His projects include developing activatable bionic probes targeting macrophages for early heart transplant rejection diagnosis, utilizing smart fluorescence/photoacoustic molecular probes for acute rejection diagnosis, and innovating rapid SARS-CoV-2 antibody detection methods. These efforts are supported by various foundations and institutions, highlighting his contributions to both clinical and research fields. Dr. Gao’s work underscores a commitment to integrating advanced biomedical technologies for improving patient outcomes and healthcare efficacy. 🧬

Academic awards

Dr. Tang Gao has achieved remarkable recognition in the field of medicine, notably earning accolades such as the Outstanding Doctoral Dissertation of Hunan Province and being named among the Outstanding Graduates of the region. His contributions to natural science have been acknowledged with the Second Prize of the Natural Science Award of Hunan Province. Additionally, he has been honored with the Chinese Medical Association Youth Science and Technology Award, highlighting his dedication and innovation in medical research and practice. 🌟 Dr. Gao’s accomplishments underscore his commitment to advancing healthcare and scientific knowledge.

Publications Top Notes

 

Nastaran Heydarikhayat | Health Professions Award | Best Researcher Award

Posted on by ScienceFather

Dr. Nastaran Heydarikhayat | Health Professions Award | Best Researcher Award

Dr. Nastaran Heydarikhayat, Iranshahr University of Medical Sciences, Iran

Dr. Nastaran Heydarikhayat is a distinguished faculty member at Iranshahr University of Medical Sciences, specializing in nursing with extensive expertise in patient safety and burn survivor care. With a doctorate from Shahid Beheshti University, her research spans qualitative studies in nursing, including the impact of COVID-19 on healthcare professionals and home care efficacy for burn survivors. Dr. Heydarikhayat has authored numerous articles in reputable journals and collaborated internationally on healthcare innovations. Recognized for her contributions, she continues to lead impactful research projects, demonstrating dedication to advancing nursing education and patient care. 🌐✨

 

Publication profile

Google Scholar

Academic and Professional Background

With a Ph.D. in nursing from Shahid Beheshti University, Heydarikhayat’s career includes impactful research on patient safety and burn survivor care. 🏥

 

Research Focus

Nastaran Heydarikhayat’s research spans diverse areas within nursing, emphasizing qualitative and quantitative studies focused on patient care and healthcare systems. 🏥 Her notable contributions include studies on burn survivor care, patient safety, and the psychological impacts of home care interventions. Through extensive clinical trials and qualitative analyses, Heydarikhayat has explored topics such as nurse-patient interactions during triage, coping strategies among medical students, and the lived experiences of nurses caring for COVID-19 patients. Her work not only enhances understanding in these critical areas but also contributes significantly to improving healthcare practices and policies. 🌟

 

Publication Top Notes